Value of Pyrazinamide for Composition of New Treatment Regimens for Multidrug-Resistant Mycobacterium Tuberculosis in China

BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-020-4758-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC